FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20201202E00054
1. Date of relevant event: 27/11/2020
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 02500
4. Name of listed corporation: Venus Medtech (Hangzhou) Inc. - B - H Shares 
5. Class of shares: H Shares 
6. Number of issued shares in class: 413,664,949
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) Leung
(Other names) Nisa Bernice Wing-Yu
10. Name of director (Chinese): 梁頴宇 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1113The number of shares in which you are interested has increased because:
any other event (you must briefly describe the relevant event in the Supplementary Information box)
 
 
2201Interest of corporation controlled by you
 
37,185,479         
 
Short position 
 
 
 
           
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position30,342,50115.08
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position67,527,98016.32
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2201Interest of corporation controlled by you
Long position67,527,980
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
           
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
Qiming Corporate GP III, Ltd.Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands (Cayman Islands)Nisa Bernice Wing-Yu Leung33.33N
Long position67,527,980
Qiming GP III, L.P.Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands (Cayman Islands)Qiming Corporate GP III, Ltd.100.00N
Long position67,527,980
Qiming Venture Partners III, L.P.Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands (Cayman Islands)Qiming GP III, L.P.100.00N
Long position47,131,229
Ming Zhi Investments LimitedUnit 4205 - 4206, 42th Floor, Gloucester Tower, The Landmark, 15 Queen's Road Central, Hong Kong (Hong Kong)Qiming Venture Partners III, L.P.96.94N
Long position47,131,229
Ming Zhi Investments (BVI) LimitedVistra Corporate Services Centre, Wickhams Cay II, Road Town, Tortola, VG1110, British Virgin Islands (British Virgin Islands)Ming Zhi Investments Limited100.00Y
Long position47,131,229
Qiming Venture Partners III Annex Fund, L.P.Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands (Cayman Islands)Qiming GP III, L.P.100.00N
Long position20,396,751
QM22 LimitedUnits 4205-4206, 42th Floor, Gloucester Tower, The Landmark, 15 Queen's Road Central, Hong Kong (Hong Kong)Qiming Venture Partners III Annex Fund, L.P.100.00N
Long position20,396,751
QM22 (BVI) LimitedVistra Corporate Services Centre, Wickhams Cay II, Road Town, Tortola, VG1110, British Virgin Islands (British Virgin Islands)QM22 Limited100.00Y
Long position20,396,751
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
  
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: Venus Medtech (Hangzhou) Inc. (the "Company") has completed the H share full circulation on November 27, 2020 where 212,450,085 unlisted and unpledged domestic shares of the Company have been converted into H shares. As a result of the foregoing, all unlisted domestic shares which Ms. Leung was interested have been fully converted into H shares. Please refer to the announcements of the Company dated August 14, 2020, November 23, 2020 and November 27, 2020 for more details.
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 02/12/2020
(dd/mm/yyyy)